Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26,414 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.
Connor RI, Korber BT, Graham BS, Hahn BH, Ho DD, Walker BD, Neumann AU, Vermund SH, Mestecky J, Jackson S, Fenamore E, Cao Y, Gao F, Kalams S, Kunstman KJ, McDonald D, McWilliams N, Trkola A, Moore JP, Wolinsky SM. Connor RI, et al. Among authors: cao y. J Virol. 1998 Feb;72(2):1552-76. doi: 10.1128/JVI.72.2.1552-1576.1998. J Virol. 1998. PMID: 9445059 Free PMC article. Clinical Trial.
Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.
Moore JP, Cao Y, Qing L, Sattentau QJ, Pyati J, Koduri R, Robinson J, Barbas CF 3rd, Burton DR, Ho DD. Moore JP, et al. Among authors: cao y. J Virol. 1995 Jan;69(1):101-9. doi: 10.1128/JVI.69.1.101-109.1995. J Virol. 1995. PMID: 7527081 Free PMC article.
Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement.
Kostrikis LG, Cao Y, Ngai H, Moore JP, Ho DD. Kostrikis LG, et al. Among authors: cao y. J Virol. 1996 Jan;70(1):445-58. doi: 10.1128/JVI.70.1.445-458.1996. J Virol. 1996. PMID: 8523557 Free PMC article.
26,414 results
You have reached the last available page of results. Please see the User Guide for more information.